The trademark BIOVANT was filed by BioSante Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on January 20, 2002, and received one opposition filed on April 3, 2002 by ILH- Immunologisches Laboratorium Hannover on Likelihood of confusion. the opponent was represented by UEXKÜLL & STOLBERG PARTNERSCHAFT VON PATENT- UND RECHTSANWÄLTEN MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued April 3, 2002
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Two renewals of the trademark were recorded, one on June 30, 2011, and the other one on February 25, 2022.
of the trademark registration was recorded on June 30, 2011. of the trademark registration was recorded on February 25, 2022. Appointment and Replacement of representative of the trademark registration was recorded on May 23, 2002. A transfer of the trademark registration was recorded on May 6, 2007.
The Appeal with reference B R0370/2003-2 was Opposition rejected according to Article 41(3) CTMR with decision issued on May 2, 2004 by the EUIPO. The Opposition with reference B 000499964 was rejected according to Rule 20(1) CTMIR with decision issued on March 30, 2003 by the EUIPO.